BSE filing, NSE: VTMLTD. Summary written from the filing by ALFA Finder's alert engine.
VTM Ltd: key numbers
- Share price
- ₹42.89
- Market cap
- ₹431.3 Cr
- Revenue (annual)
- ₹372.0 Cr
- Net profit (annual)
- ₹11.20 Cr
- P/E (TTM)
- 50.6×Sector 49.5×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from VTM Ltd
All →VTM Board Meeting Date
VTM Ltd intimates a board meeting on 5 November 2026 to consider unaudited Q2 and H1 FY27 results alongside other agenda items. The meeting has not yet been held, so no results are approved yet.
VTM Price Movement Clarification
VTM Limited clarified to exchanges that recent share price movements are purely market-driven. The company confirmed it has disclosed all material information and is unaware of any internal developments causing the fluctuation.
VTM Other Announcement
VTM Ltd has filed its periodic shareholding pattern disclosure as of September 4, 2026, in compliance with SEBI regulations. This filing details the company's current ownership structure.
VTM Management Change
Company Secretary and Compliance Officer Ms. K. Preyatharshine has resigned from VTM Ltd. The resignation is effective from August 14, 2026.
VTM Q1 FY27 Results: Net Profit ₹1.9 Cr, Down 58.7% YoY
VTM Ltd reported revenue from operations of ₹98.4 Cr (+36.7% YoY) and net profit of ₹1.9 Cr (-58.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.9 Cr · -58.7% YoY
VTM Board Meeting Date
VTM Ltd has scheduled a Board Meeting on August 12, 2026, to consider the quarterly financial results and address proposed management changes.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.